News
In vitro disease models that could lead to new therapiesCPHI Online
www.cphi-online.com
— ... quality control tests as their healthy counterparts from our human primary cell portfolio,” adds Dr. Irma Boercsoek, COO of PromoCell.
PromoCell's New GMP Certification - EXCiPACTNews Medical
www.news-medical.net
— Dr. Irma Börcsök received her PhD degree in Biology from the University of Heidelberg (Germany), focusing on studying osteonecrotic bone ...
Cells That Could Lead to New Therapies: Promocell Now Offers in Vitro...
www.labmanager.com
New models can help researchers investigate disease development and find new treatment approaches
PromoCell now offers in vitro disease models that could lead ...
www.worldpharmatoday.com
... cell portfolio,” adds Dr. Irma Boercsoek, COO of PromoCell. The tests include cell factors marker characterization, growth performance and morphology. › ...
sortiert nach Relevanz / Datum